Neural Analytics said that clinical data from its transcranial Doppler ultrasound technology will be presented at this week's European Society of Neurosonology and Cerebral Hemodynamics (ESNCH) meeting in Prague.
The company's investigational NeuralBot accessory to its Lucid M1 system will be featured in six abstracts, two oral presentations, and four scientific posters, according to the firm. NeuralBot uses ultrasound to assess the brain's blood vessels from outside the body, while Lucid M1 monitors blood flow velocities in the cerebral vasculature, Neural Analytics said.
